Pelvic Floor Therapies for Lifelong Premature Ejaculation
NCT: NCT07627438 · RECRUITING
Brief Summary
This randomized controlled trial will compare three pelvic floor-based treatment modalities in men with lifelong premature ejaculation: electromagnetic pelvic floor stimulation, biofeedback-assisted pelvic floor muscle training, and conventional pelvic floor muscle training. A total of 150 men aged 18 to 50 years with lifelong premature ejaculation and stopwatch-measured intravaginal ejaculatory latency time of less than 1 minute will be randomly assigned to one of the three treatment groups. The primary outcome will be the change in intravaginal ejaculatory latency time from baseline to the end of treatment at 6 weeks. Secondary outcomes will include changes in Premature Ejaculation Diagnostic Tool score, International Index of Erectile Function-5 score, patient-reported ejaculatory control, sexual satisfaction, partner satisfaction, treatment adherence, and adverse events.
Frequently Asked Questions
What is Pelvic Floor Therapies for Lifelong Premature Ejaculation?
Pelvic Floor Therapies for Lifelong Premature Ejaculation is a clinical trial registered under NCT07627438. Current status: RECRUITING.
What is the status of NCT07627438?
The current status of NCT07627438 (Pelvic Floor Therapies for Lifelong Premature Ejaculation) is: RECRUITING.
When did Pelvic Floor Therapies for Lifelong Premature Ejaculation start?
Pelvic Floor Therapies for Lifelong Premature Ejaculation started on 2026-04-26.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.